VNDA
Vanda Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
6.37 / 10
Outperform
Sentiment scores 6.37 (Outperform) and fund‑flow 7.88 (good), showing strong inflows across most investor sizes except medium. Two analysts issue Strong Buy recommendations, though one has a 0% historical win rate. Momentum is positive but price has fallen 21.6%.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-05
InstitutionTruist Securities
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of VNDA?
- VNDA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.37/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
